N-Acetylcysteine and Its Immunomodulatory Properties in Humans and Domesticated Animals
Antioxidants · 16.10.2023 · 12 (10) · 1867
DOI: 10.3390/antiox12101867 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Antioxidants, online erschienen am 16.10.2023. Verfasst von Sophie Tieu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Animal Biosciences, University of Guelph, Guelph, ON N1G 2W1, Canada. Die Arbeit wurde bisher 57-mal zitiert (Crossref) und nennt 219 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
N-acetylcysteine (NAC), an acetylated derivative of the amino acid L-cysteine, has been widely used as a mucolytic agent and antidote for acetaminophen overdose since the 1960s and the 1980s, respectively. NAC possesses antioxidant, cytoprotective, anti-inflammatory, antimicrobial, and mucolytic properties, making it a promising therapeutic agent for a wide range of diseases in both humans and domesticated animals. Oxidative stress and inflammation play a major role in the onset and progression of all these diseases. NAC’s primary role is to replenish glutathione (GSH) stores, the master antioxidant in all tissues; however, it can also reduce levels of pro-inflammatory tumor necrosis factor-alpha (TNF-∝) and interleukins (IL-6 and IL-1β), inhibit the formation of microbial biofilms and destroy biofilms, and break down disulfide bonds between mucin molecules. Many experimental studies have been conducted on the use of NAC to address a wide range of pathological conditions; however, its effectiveness in clinical trials remains limited and studies often have conflicting results. The purpose of this review is to provide a concise overview of promising NAC usages for the treatment of different human and domestic animal disorders.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Animal Biosciences, University of Guelph, Guelph, ON N1G 2W1, Canada.
- Department of Pathobiology, University of Guelph, Guelph, ON N1G 2W1, Canada.
- ImmunoCeutica Inc., Cambridge, ON N1T 1N6, Canada.
- Advanced Analysis Centre, University of Guelph, Guelph, ON N1G 2W1, Canada.
ORCID-Profile: Umesh K Shandilya, Byram W Bridle
Zitieren
APA
Tieu, S., Charchoglyan, A., Paulsen, L., Wagter-Lesperance, L. C., Shandilya, U. K., Bridle, B. W., Mallard, B. A., & Karrow, N. A. (2023). N-Acetylcysteine and Its Immunomodulatory Properties in Humans and Domesticated Animals. Antioxidants, 12(10), 1867. https://doi.org/10.3390/antiox12101867
Vancouver
Tieu S, Charchoglyan A, Paulsen L, Wagter-Lesperance LC, Shandilya UK, Bridle BW, et al. N-Acetylcysteine and Its Immunomodulatory Properties in Humans and Domesticated Animals. Antioxidants. 2023;12(10):1867. doi:10.3390/antiox12101867
BibTeX
@article{Tieu2023,
author = {Tieu, Sophie and Charchoglyan, Armen and Paulsen, Lauryn and Wagter-Lesperance, Lauri C and Shandilya, Umesh K and Bridle, Byram W and Mallard, Bonnie A and Karrow, Niel A},
title = {N-Acetylcysteine and Its Immunomodulatory Properties in Humans and Domesticated Animals},
journal = {Antioxidants},
year = {2023},
volume = {12},
number = {10},
pages = {1867},
doi = {10.3390/antiox12101867}
}
EUVIMED